China SXT Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $33.5M
Liabilities Breakdown FY2022
Total Liabilities: $17.1M
Asset Breakdown
Total Assets: $33.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $15.6M | 46.4% |
| Accounts Receivable | $3.3M | 9.9% |
| Inventory | $1.0M | 3.0% |
| Property, Plant & Equipment | $1.2M | 3.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $38.8K | 0.1% |
| Other Assets | $12.4M | 36.8% |
Liabilities Breakdown
Total Liabilities: $17.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 8.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.6M | 91.3% |